[June 28, 2016]

Hemoglobin A1c Monitoring Market 2015-2022 - Global Strategic Business Report 2016 - Research and Markets

Research and Markets has announced the addition of the "Hemoglobin A1c Monitoring - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ by the following Test Types: HbA1c Laboratory Testing, and HbA1c Point of Care Testing.

The report profiles 25 companies including many key and niche players such as

• Abbott Laboratories (US)
• Alere, Inc. (US)
• ARKRAY, Inc. (Japan)
• Beckman Coulter, Inc. (US)
• Bio-Rad Laboratories, Inc. (US)
• Diazyme Laboratories Inc. (US)
• EKF Diagnostics Holdings Plc (UK)
• HemoCue® AB (Sweden)
• Infopia Co., Ltd. (South Korea)
• A.Menarini Diagnostics Ltd. (UK)
• PTS Diagnostics (US)
• Roche Diagnostics (Switzerland)
• Siemens (News - Alert) Healthineers (Germany)
• Tosoh Bioscience, Inc. (US)
• Trinity Biotech plc (Ireland)

1. MARKET OVERVIEW

2. DIABETES - A BRIEF PROFILE OF THE DISEASE

3. PRODUCT OVERVIEW

4. PRODUCT INNOVATIONS/INTRODUCTIONS

5. RECENT INDUSTRY ACTIVITY

6. FOCUS ON (News - Alert) SELECT PLAYERS

7. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 25 (including Divisions/Subsidiaries 33)

• The United States (15)
• Japan (2)
• Europe (13)
• - Germany (3)
• - The United Kingdom (4)
• - Italy (1)
• - Rest of Europe (5)
• Asia-Pacific (Excluding Japan) (3)

For more information visit http://www.researchandmarkets.com/research/h24jl9/hemoglobin_a1c

View source version on businesswire.com: http://www.businesswire.com/news/home/20160628006205/en/

[ Back To TMCnet.com's Homepage ]